BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 29202439)

  • 21. Comparative dissolution studies for mefenamic acid-polyethylene glycol solid dispersion systems and tablets.
    Owusu-Ababio G; Ebube NK; Reams R; Habib M
    Pharm Dev Technol; 1998 Aug; 3(3):405-12. PubMed ID: 9742561
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of drug load on dissolution behavior of tablets containing a poorly water-soluble drug: estimation of the percolation threshold.
    Wenzel T; Stillhart C; Kleinebudde P; Szepes A
    Drug Dev Ind Pharm; 2017 Aug; 43(8):1265-1275. PubMed ID: 28398095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mefenamic acid-loaded solid SMEDDS: an innovative aspect for dose reduction and improved pharmacodynamic profile.
    Kumar M; Singh D; Bedi N
    Ther Deliv; 2019 Jan; 10(1):21-36. PubMed ID: 30730824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide tablets.
    Tomuta I; Rus L; Iovanov R; Rus LL
    J Pharm Biomed Anal; 2013 Oct; 84():285-92. PubMed ID: 23347649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Blend uniformity end-point determination using near-infrared spectroscopy and multivariate calibration.
    Sulub Y; Konigsberger M; Cheney J
    J Pharm Biomed Anal; 2011 Jun; 55(3):429-34. PubMed ID: 21398064
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development and validation of an in-line NIR spectroscopic method for continuous blend potency determination in the feed frame of a tablet press.
    De Leersnyder F; Peeters E; Djalabi H; Vanhoorne V; Van Snick B; Hong K; Hammond S; Liu AY; Ziemons E; Vervaet C; De Beer T
    J Pharm Biomed Anal; 2018 Mar; 151():274-283. PubMed ID: 29413975
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Some physicochemical properties of mefenamic acid.
    Adam A; Schrimpl L; Schmidt PC
    Drug Dev Ind Pharm; 2000 May; 26(5):477-87. PubMed ID: 10789059
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dissolution assessment of allopurinol immediate release tablets by near infrared spectroscopy.
    Smetiško J; Miljanić S
    J Pharm Biomed Anal; 2017 Oct; 145():322-330. PubMed ID: 28709129
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determination of the main solid-state form of albendazole in bulk drug, employing Raman spectroscopy coupled to multivariate analysis.
    Calvo NL; Arias JM; Altabef AB; Maggio RM; Kaufman TS
    J Pharm Biomed Anal; 2016 Sep; 129():190-197. PubMed ID: 27429368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting the dissolution behavior of pharmaceutical tablets with NIR chemical imaging.
    Yekpe K; Abatzoglou N; Bataille B; Gosselin R; Sharkawi T; Simard JS; Cournoyer A
    Int J Pharm; 2015; 486(1-2):242-51. PubMed ID: 25835268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-throughput NIR-chemometric methods for determination of drug content and pharmaceutical properties of indapamide powder blends for tabletting.
    Porfire A; Rus L; Vonica AL; Tomuta I
    J Pharm Biomed Anal; 2012 Nov; 70():301-9. PubMed ID: 22884785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dissolution and assaying of multicomponent tablets by chemometric methods using computer-aided spectrophotometer.
    Dinç E; Serin C; Tuğcu-Demiröz F; Doğanay T
    Int J Pharm; 2003 Jan; 250(2):339-50. PubMed ID: 12527161
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Process analytical technology: chemometric analysis of Raman and near infra-red spectroscopic data for predicting physical properties of extended release matrix tablets.
    Shah RB; Tawakkul MA; Khan MA
    J Pharm Sci; 2007 May; 96(5):1356-65. PubMed ID: 17455359
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Solubility behavior of polymorphs I and II of mefenamic acid in solvent mixtures.
    Romero S; Escalera B; Bustamante P
    Int J Pharm; 1999 Feb; 178(2):193-202. PubMed ID: 10205639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prediction of Dissolution Profiles From Process Parameters, Formulation, and Spectroscopic Measurements.
    Zhao Y; Li W; Shi Z; Drennen JK; Anderson CA
    J Pharm Sci; 2019 Jun; 108(6):2119-2127. PubMed ID: 30742835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prediction of drug dissolution from tablets using near-infrared diffuse reflectance spectroscopy as a nondestructive method.
    Donoso M; Ghaly ES
    Pharm Dev Technol; 2004 Aug; 9(3):247-63. PubMed ID: 15458231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Near-infrared chemical imaging (NIR-CI) as a process monitoring solution for a production line of roll compaction and tableting.
    Khorasani M; Amigo JM; Sun CC; Bertelsen P; Rantanen J
    Eur J Pharm Biopharm; 2015 Jun; 93():293-302. PubMed ID: 25917640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemometric and derivative methods as flexible spectrophotometric approaches for dissolution and assaying tests in multicomponent tablets.
    Markopoulou CK; Malliou ET; Koundourellis JE
    Farmaco; 2004 Aug; 59(8):627-36. PubMed ID: 15262532
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of powder blend uniformity: Comparison of real-time NIR blend monitoring with stratified sampling in combination with HPLC and at-line NIR Chemical Imaging.
    Bakri B; Weimer M; Hauck G; Reich G
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):78-89. PubMed ID: 26455421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Simultaneous quantification of artesunate and mefloquine in fixed-dose combination tablets by multivariate calibration with middle infrared spectroscopy and partial least squares regression.
    Marson BM; de Oliveira Vilhena R; de Souza Madeira CR; Pontes FL; Piantavini MS; Pontarolo R
    Malar J; 2016 Feb; 15():109. PubMed ID: 26911371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.